• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

Professional Introduction to 2-Bromo-3-bromomethyl-6-(trifluoromethyl)pyridine (CAS No. 888738-20-3)

2-Bromo-3-bromomethyl-6-(trifluoromethyl)pyridine, with the chemical formula C?H?Br?F?N, is a highly versatile intermediate in the field of pharmaceutical and agrochemical research. This compound, identified by its CAS number 888738-20-3, has garnered significant attention due to its unique structural properties and potential applications in the synthesis of bioactive molecules. The presence of multiple bromine substituents and a trifluoromethyl group makes it a valuable building block for further functionalization, enabling the development of novel compounds with enhanced biological activity.

The compound's structure consists of a pyridine core, which is a common scaffold in many pharmacologically active agents. The pyridine ring itself is aromatic and electron-deficient, making it an attractive site for various chemical transformations. Specifically, the 2-bromo and 3-bromomethyl substituents provide reactive sites for cross-coupling reactions, such as Suzuki-Miyaura and Negishi couplings, which are widely employed in medicinal chemistry to construct complex molecular architectures. Additionally, the 6-(trifluoromethyl) group introduces electronic and steric effects that can influence the pharmacokinetic properties of derived compounds.

In recent years, there has been a growing interest in fluorinated pyridines due to their ability to improve metabolic stability, lipophilicity, and binding affinity towards biological targets. The trifluoromethyl group, in particular, is known for its ability to enhance the binding interactions between a drug molecule and its target protein. This property has been leveraged in the development of various therapeutic agents, including antiviral, anticancer, and anti-inflammatory drugs. The compound 2-Bromo-3-bromomethyl-6-(trifluoromethyl)pyridine is no exception and has been explored in several synthetic routes aimed at generating novel fluorinated heterocycles.

One of the most notable applications of this compound is in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in many cellular processes and are often targeted by therapeutic agents. The brominated pyridine intermediate serves as a key precursor in the preparation of small-molecule inhibitors that disrupt kinase activity. For instance, studies have demonstrated its utility in generating inhibitors targeting tyrosine kinases, which are implicated in various cancers. The ability to introduce additional functional groups via cross-coupling reactions allows for fine-tuning of the inhibitor's properties to optimize its efficacy and selectivity.

The agrochemical industry has also benefited from the use of 2-Bromo-3-bromomethyl-6-(trifluoromethyl)pyridine. Fluorinated pyridines are known to exhibit potent activity against a range of pests and pathogens. By serving as a precursor for the synthesis of novel agrochemicals, this compound contributes to the development of more effective and sustainable crop protection agents. The bromine substituents facilitate further modifications that can enhance the bioactivity and environmental profile of these compounds.

Recent advances in synthetic methodologies have further expanded the utility of 2-Bromo-3-bromomethyl-6-(trifluoromethyl)pyridine. Transition-metal-catalyzed reactions have become particularly valuable tools for constructing complex molecular frameworks efficiently. For example, palladium-catalyzed cross-coupling reactions have been used to introduce aryl or vinyl groups at various positions on the pyridine ring. These transformations have enabled the preparation of diverse derivatives with tailored biological properties.

The compound's reactivity also makes it suitable for applications in material science. Fluorinated pyridines can be incorporated into polymers and coatings to impart specific functionalities, such as hydrophobicity or thermal stability. The bromine atoms provide handles for further chemical modifications, allowing for the creation of materials with customized properties.

In conclusion, 2-Bromo-3-bromomethyl-6-(trifluoromethyl)pyridine (CAS No. 888738-20-3) is a multifaceted intermediate with significant potential in pharmaceuticals, agrochemicals, and materials science. Its unique structural features enable diverse chemical transformations, making it an indispensable tool for synthetic chemists. As research continues to uncover new applications for fluorinated heterocycles, this compound will undoubtedly remain at the forefront of innovation in chemical synthesis.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)